TrialBMC complementary medicine and therapies2021

Efficacy and safety of Kami-guibi-tang for mild cognitive impairment: a pilot, randomized, double-blind, placebo-controlled trial.

Hee-Yeon Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.